OLBA HEALTHCARE HOLDINGS,Inc.
TSE Standard
¥1,926.00
-1.18%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Comfortable interest cover: operating profit covers interest about 52.6 times.
- Return on equity is moderate at 12.1%.
- Return on capital employed is moderate at 12.3%.
- Has paid a dividend in each of the last 5 years on record.
!Watch-points
- Higher leverage: debt-to-equity of 2.74 is above 1.
- Net profit margin is slim at 1.2%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
3.35
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreWeak
2 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap¥114億
Current Price¥ 1,926.00
High / Low¥ 2,238.00 / 1,780.00
Stock P/E10.267072
Book Value¥ 2,068.59
Dividend Yield4.1%
ROCE12.34%
ROE12.10%
Debt to Equity2.74
Current Ratio1.24
P/B Ratio0.8742251
EPS¥ 241.43
PAT Margin1.17%
ICR52.55
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity